Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
about
SAK-HV Triggered a Short-period Lipid-lowering Biotherapy Based on the Energy Model of Liver Proliferation via a Novel Pathway.Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat dietAtorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.Endothelial relaxation mechanisms and oxidative stress are restored by atorvastatin therapy in ovariectomized rats.Influence of fatty acids in maternal diet on atherogenesis in offspring of LDL receptor-deficient miceHyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.Pharmacotherapy of coronary atherosclerosis.Statins and vein graft failure in coronary bypass surgery.Effect of statins on chronic inflammation and nutrition status in renal dialysis patients: a systematic review and meta-analysis.In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatinLeucine-nicotinic acid synergy stimulates AMPK/Sirt1 signaling and regulates lipid metabolism and lifespan in Caenorhabditis elegans, and hyperlipidemia and atherosclerosis in mice.Comparative study between atorvastatin and losartan on high fat diet-induced type 2 diabetes mellitus in rats.
P2860
Q33703148-4B72894F-8572-4A3F-9044-3A779674710EQ34027495-239B4E88-60DB-4140-BA2F-868A2DD62E2FQ34541085-7B5FF795-725C-4253-8BCA-F670DF69D7BEQ34565278-B773A2E3-1FBC-4EBA-904F-0D8F6E757D86Q35053761-10BB6496-CE9F-4386-A5ED-3C5F83D1CC91Q35738545-84D17A58-F21C-4BE3-A305-755C344B7553Q36387245-B27E9D26-97F2-4BEE-B4C6-BD5E23AD8903Q37519710-EEFD064F-4CEE-4DE4-993B-35D26FA13599Q37983344-5F7ACC95-A68F-4B7A-A8C3-930B877EDA7CQ37994887-52D3D33A-0478-48A8-997C-6951EB4C404CQ41480230-9650B63D-AB69-42F5-8963-34BFDFFE0319Q41877399-2473B9A6-70C8-4450-B226-8CF75871237EQ51355375-732AF9DF-9F17-4FAC-B919-DA342AC0B5A8
P2860
Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Atorvastatin has hypolipidemic ...... receptor-double-knockout mice.
@en
Atorvastatin has hypolipidemic ...... receptor-double-knockout mice.
@nl
type
label
Atorvastatin has hypolipidemic ...... receptor-double-knockout mice.
@en
Atorvastatin has hypolipidemic ...... receptor-double-knockout mice.
@nl
prefLabel
Atorvastatin has hypolipidemic ...... receptor-double-knockout mice.
@en
Atorvastatin has hypolipidemic ...... receptor-double-knockout mice.
@nl
P2093
P1433
P1476
Atorvastatin has hypolipidemic ...... receptor-double-knockout mice.
@en
P2093
Ctirad Andrys
Dagmar Solichova
Gabriela Jamborova
Katerina Pospechova
Nada Pospisilova
Petr Zdansky
Vladimir Semecky
P304
P356
10.1016/J.LFS.2008.01.006
P407
P577
2008-01-26T00:00:00Z